News

US states are piling more pressure onto private equity healthcare teams. Plus: a new Vitruvian man; and Carlyle co-founder David Rubenstein has come into some liquidity. Here's today's brief, for our valued subscribers only.

Japan could be in contention for Advent’s next stage of Asia-Pacific expansion after the firm’s newly opened Australia office, India head Shweta Jalan tells PEI.

In a brutal fundraising market for emerging managers, commitments from GCM Grosvenor/CalPERS and New York Common provide a leg up for Excolere’s debut vehicle, recently rolled out with a $400m target.

The deal is part of a series of large LP sales that is being driven by liquidity concerns, the need to rebalance investment exposures in investment portfolios and strong pricing for high-quality private markets funds.

Via its Capital Constellation platform, the NY alternative manager is adding a European software data-focused PE firm to its sizable portfolio of GP investments.

CalPERS staff explain why they're betting billions on emerging managers. Plus: Alaska's PE director receives an expanded investment remit; and LPs are becoming much more optimistic about distributions. Here's today's brief, for our valued subscribers only.

The Paris-based manager is set to be back in the market with its sophomore secondaries fund in early 2025, following closes for its flagship and emerging manager funds.

Fundraising for healthcare vehicles almost doubled last year and our latest special report examines where the money will be spent. Plus: LP portfolio management on the up and Temasek subsidiary's credit move. Here's today's brief, for our valued subscribers only.

NewView was spun out of Silicon Valley venture giant NEA in 2018 through a $1.35bn secondaries deal backed by Goldman Sachs and Hamilton Lane.